{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T20:44:42Z","timestamp":1754599482467,"version":"3.40.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NSRF under the Basic Research Fund of Khon Kaen University through Cholangiocarcinoma Research Institute.","award":["CARI-BRF64-33"],"award-info":[{"award-number":["CARI-BRF64-33"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-96442-4","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T12:54:55Z","timestamp":1744116895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identifying a unique chromosomal pattern to predict the gemcitabine response in patients with cholangiocarcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Sutheemon","family":"Techa-ay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasithorn","family":"Watcharadetwittaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raksawan","family":"Deenonpoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakasit","family":"Sa-ngiamwibool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanita","family":"Panwoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Watcharin","family":"Loilome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poramate","family":"Klanrit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anchalee","family":"Techasen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaovalux","family":"Chamgramol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manida","family":"Suksawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Napat","family":"Armartmuntree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Saya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malinee","family":"Thanee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"96442_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/hep.22310","volume":"48","author":"B Blechacz","year":"2008","unstructured":"Blechacz, B. & Gores, G. J. Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment. Hepatology 48, 308\u2013321. https:\/\/doi.org\/10.1002\/hep.22310 (2008).","journal-title":"Hepatology"},{"key":"96442_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","volume":"224","author":"A Nakeeb","year":"1996","unstructured":"Nakeeb, A. et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann. Surg. 224, 463\u2013473. https:\/\/doi.org\/10.1097\/00000658-199610000-00005 (1996). discussion 473\u2009\u2013\u2009465.","journal-title":"Ann. Surg."},{"key":"96442_CR3","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1136\/gut.2007.138859","volume":"56","author":"SA Khan","year":"2007","unstructured":"Khan, S. A., Miras, A., Pelling, M. & Taylor-Robinson, S. D. Cholangiocarcinoma and its management. Gut 56, 1755\u20131756. https:\/\/doi.org\/10.1136\/gut.2007.138859 (2007).","journal-title":"Gut"},{"key":"96442_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/jjco\/hye134","volume":"32 Suppl","author":"V Vatanasapt","year":"2002","unstructured":"Vatanasapt, V., Sriamporn, S. & Vatanasapt, P. Cancer control in Thailand. Jpn J. Clin. Oncol. 32 Suppl, 82\u201391. https:\/\/doi.org\/10.1093\/jjco\/hye134 (2002).","journal-title":"Jpn J. Clin. Oncol."},{"key":"96442_CR5","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle, J. et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl. J. Med. 362, 1273\u20131281. https:\/\/doi.org\/10.1056\/NEJMoa0908721 (2010).","journal-title":"N Engl. J. Med."},{"key":"96442_CR6","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1111\/jgh.12321","volume":"28","author":"K Wirasorn","year":"2013","unstructured":"Wirasorn, K. et al. Adjuvant chemotherapy in resectable cholangiocarcinoma patients. J. Gastroenterol. Hepatol. 28, 1885\u20131891. https:\/\/doi.org\/10.1111\/jgh.12321 (2013).","journal-title":"J. Gastroenterol. Hepatol."},{"doi-asserted-by":"crossref","unstructured":"Brandi, G. & Rizzo, A. I. D. H. Inhibitors and immunotherapy for biliary tract cancer: A marriage of convenience? 23, 10869 (2022).","key":"96442_CR7","DOI":"10.3390\/ijms231810869"},{"key":"96442_CR8","doi-asserted-by":"publisher","first-page":"479","DOI":"10.21873\/invivo.11798","volume":"34","author":"A Rizzo","year":"2020","unstructured":"Rizzo, A. et al. Anti-EGFR monoclonal antibodies in advanced biliary tract cancer: A systematic review and meta-analysis. Vivo 34, 479\u2013488. https:\/\/doi.org\/10.21873\/invivo.11798 (2020).","journal-title":"Vivo"},{"key":"96442_CR9","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.21873\/anticanres.14282","volume":"40","author":"A Rizzo","year":"2020","unstructured":"Rizzo, A. et al. Second-line treatment in advanced biliary tract cancer: Today and tomorrow. Anticancer Res. 40, 3013\u20133030. https:\/\/doi.org\/10.21873\/anticanres.14282 (2020).","journal-title":"Anticancer Res."},{"key":"96442_CR10","doi-asserted-by":"publisher","first-page":"EVIDoa2200015","DOI":"10.1056\/EVIDoa2200015","volume":"1","author":"DY Oh","year":"2022","unstructured":"Oh, D. Y. et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid. 1, EVIDoa2200015. https:\/\/doi.org\/10.1056\/EVIDoa2200015 (2022).","journal-title":"NEJM Evid."},{"key":"96442_CR11","doi-asserted-by":"publisher","first-page":"e001042","DOI":"10.1136\/esmoopen-2020-001042","volume":"5","author":"AD Ricci","year":"2020","unstructured":"Ricci, A. D., Rizzo, A. & Brandi, G. The DNA damage repair (DDR) pathway in biliary tract cancer (BTC): A new Pandora\u2019s box? ESMO Open 5, e001042. https:\/\/doi.org\/10.1136\/esmoopen-2020-001042 (2020).","journal-title":"ESMO Open"},{"doi-asserted-by":"publisher","unstructured":"Jakubowski, C. D. & Azad, N. S. Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma). Chin. Clin. Oncol. 9. https:\/\/doi.org\/10.21037\/cco.2019.12.10 (2020).","key":"96442_CR12","DOI":"10.21037\/cco.2019.12.10"},{"key":"96442_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/mc.22925","volume":"58","author":"CN Yeh","year":"2019","unstructured":"Yeh, C. N. et al. Over-expression of TNNI3K is associated with early-stage carcinogenesis of cholangiocarcinoma. Mol. Carcinog. 58, 270\u2013278. https:\/\/doi.org\/10.1002\/mc.22925 (2019).","journal-title":"Mol. Carcinog."},{"key":"96442_CR14","doi-asserted-by":"publisher","first-page":"10637","DOI":"10.1038\/s41598-018-28941-6","volume":"8","author":"R Jansen","year":"2018","unstructured":"Jansen, R. et al. ACGH detects distinct genomic alterations of primary intrahepatic cholangiocarcinomas and matched lymph node metastases and identifies a poor prognosis subclass. Sci. Rep. 8, 10637. https:\/\/doi.org\/10.1038\/s41598-018-28941-6 (2018).","journal-title":"Sci. Rep."},{"key":"96442_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2020-207346","author":"I Tavares","year":"2021","unstructured":"Tavares, I. et al. Development of a genomic predictive model for cholangiocarcinoma using copy number alteration data. J. Clin. Pathol. https:\/\/doi.org\/10.1136\/jclinpath-2020-207346 (2021).","journal-title":"J. Clin. Pathol."},{"doi-asserted-by":"crossref","unstructured":"Liu, C. J. et al. GSCALite: a web server for gene set cancer analysis. Bioinformatics 34, 3771\u20133772. https:\/\/doi.org\/10.1093\/bioinformatics\/bty411%J (2018).","key":"96442_CR16","DOI":"10.1093\/bioinformatics\/bty411"},{"key":"96442_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-1-4939-7745-1_8","volume":"1760","author":"RM Hoffman","year":"2018","unstructured":"Hoffman, R. M., Jung, P. S., Kim, M. B. & Nam, J. H. Prospective clinical correlation of the histoculture drug response assay for ovarian cancer. Methods Mol. Biol. 1760, 73\u201381. https:\/\/doi.org\/10.1007\/978-1-4939-7745-1_8 (2018).","journal-title":"Methods Mol. Biol."},{"key":"96442_CR18","doi-asserted-by":"publisher","first-page":"W652","DOI":"10.1093\/nar\/gkp356","volume":"37","author":"J Xia","year":"2009","unstructured":"Xia, J., Psychogios, N., Young, N. & Wishart, D. S. MetaboAnalyst: A web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 37, W652\u2013660. https:\/\/doi.org\/10.1093\/nar\/gkp356 (2009).","journal-title":"Nucleic Acids Res."},{"key":"96442_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12885-020-6655-4","volume":"20","author":"S Padthaisong","year":"2020","unstructured":"Padthaisong, S. et al. A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma. BMC Cancer 20, 154. https:\/\/doi.org\/10.1186\/s12885-020-6655-4 (2020).","journal-title":"BMC Cancer"},{"key":"96442_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40170-021-00266-5","volume":"9","author":"S Padthaisong","year":"2021","unstructured":"Padthaisong, S. et al. Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma. Cancer Metab. 9, 30. https:\/\/doi.org\/10.1186\/s40170-021-00266-5 (2021).","journal-title":"Cancer Metab."},{"key":"96442_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/path.2021","volume":"210","author":"R Natrajan","year":"2006","unstructured":"Natrajan, R. et al. Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse. J. Pathol. 210, 49\u201358. https:\/\/doi.org\/10.1002\/path.2021 (2006).","journal-title":"J. Pathol."},{"key":"96442_CR22","doi-asserted-by":"publisher","first-page":"6791","DOI":"10.1073\/pnas.87.17.6791","volume":"87","author":"H Tsuda","year":"1990","unstructured":"Tsuda, H. et al. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. Natl. Acad. Sci. U S A 87, 6791\u20136794. https:\/\/doi.org\/10.1073\/pnas.87.17.6791 (1990).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"96442_CR23","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1158\/0008-5472.CAN-15-2564","volume":"76","author":"M Wang","year":"2016","unstructured":"Wang, M. et al. Genome-wide association study of bladder cancer in a Chinese cohort reveals a new susceptibility locus at 5q12.3. Cancer Res. 76, 3277\u20133284. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2564 (2016).","journal-title":"Cancer Res."},{"key":"96442_CR24","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1093\/hmg\/ddab319","volume":"31","author":"RE Bertrand","year":"2022","unstructured":"Bertrand, R. E. et al. Cwc27, associated with retinal degeneration, functions as a splicing factor in vivo. Hum. Mol. Genet. 31, 1278\u20131292. https:\/\/doi.org\/10.1093\/hmg\/ddab319 (2022).","journal-title":"Hum. Mol. Genet."},{"key":"96442_CR25","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/dvdy.214","volume":"249","author":"C Griffin","year":"2020","unstructured":"Griffin, C. & Saint-Jeannet, J. P. Spliceosomopathies diseases and mechanisms. Dev. Dyn. 249, 1038\u20131046. https:\/\/doi.org\/10.1002\/dvdy.214 (2020).","journal-title":"Dev. Dyn."},{"key":"96442_CR26","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ajhg.2017.02.008","volume":"100","author":"M Xu","year":"2017","unstructured":"Xu, M. et al. Mutations in the spliceosome component CWC27 cause retinal degeneration with or without additional developmental anomalies. Am. J. Hum. Genet. 100, 592\u2013604. https:\/\/doi.org\/10.1016\/j.ajhg.2017.02.008 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"96442_CR27","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1093\/nar\/gkaa267","volume":"48","author":"V Busetto","year":"2020","unstructured":"Busetto, V. et al. Structural and functional insights into CWC27\/CWC22 heterodimer linking the exon junction complex to spliceosomes. Nucleic Acids Res. 48, 5670\u20135683. https:\/\/doi.org\/10.1093\/nar\/gkaa267 (2020).","journal-title":"Nucleic Acids Res."},{"key":"96442_CR28","doi-asserted-by":"publisher","first-page":"a003129","DOI":"10.1101\/cshperspect.a003129","volume":"1","author":"G Berx","year":"2009","unstructured":"Berx, G. & van Roy, F. Involvement of members of the Cadherin superfamily in cancer. Cold Spring Harb. Perspect. Biol. 1, a003129. https:\/\/doi.org\/10.1101\/cshperspect.a003129 (2009).","journal-title":"Cold Spring Harb Perspect. Biol."},{"key":"96442_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12964-021-00728-9","volume":"19","author":"W Zheng","year":"2021","unstructured":"Zheng, W. et al. Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma. Cell. Commun. Signal. 19, 39. https:\/\/doi.org\/10.1186\/s12964-021-00728-9 (2021).","journal-title":"Cell. Commun. Signal."},{"key":"96442_CR30","doi-asserted-by":"publisher","first-page":"8498","DOI":"10.18632\/aging.204357","volume":"14","author":"SC Ku","year":"2022","unstructured":"Ku, S. C. et al. Comprehensive analysis of prognostic significance of Cadherin (CDH) gene family in breast cancer. Aging (Albany NY) 14, 8498\u20138567. https:\/\/doi.org\/10.18632\/aging.204357 (2022).","journal-title":"Aging (Albany NY)"},{"key":"96442_CR31","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1096\/fj.06-6085com","volume":"20","author":"P Riou","year":"2006","unstructured":"Riou, P. et al. Expression of T-cadherin in tumor cells influences invasive potential of human hepatocellular carcinoma. FASEB J. 20, 2291\u20132301. https:\/\/doi.org\/10.1096\/fj.06-6085com (2006).","journal-title":"FASEB J."},{"key":"96442_CR32","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1161\/01.ATV.0000238356.20565.92","volume":"26","author":"M Philippova","year":"2006","unstructured":"Philippova, M. et al. Atypical GPI-anchored T-cadherin stimulates angiogenesis in vitro and in vivo. Arterioscler. Thromb. Vasc Biol. 26, 2222\u20132230. https:\/\/doi.org\/10.1161\/01.ATV.0000238356.20565.92 (2006).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"doi-asserted-by":"publisher","unstructured":"Peppino, G. et al. Teneurins: Role in cancer and potential role as diagnostic biomarkers and targets for therapy. Int. J. Mol. Sci. 22. https:\/\/doi.org\/10.3390\/ijms22052321 (2021).","key":"96442_CR33","DOI":"10.3390\/ijms22052321"},{"key":"96442_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2012.07.021","volume":"326","author":"A Ziegler","year":"2012","unstructured":"Ziegler, A., Corvalan, A., Roa, I., Branes, J. A. & Wollscheid, B. Teneurin protein family: An emerging role in human tumorigenesis and drug resistance. Cancer Lett. 326, 1\u20137. https:\/\/doi.org\/10.1016\/j.canlet.2012.07.021 (2012).","journal-title":"Cancer Lett."},{"key":"96442_CR35","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/mc.22514","volume":"56","author":"N Arakawa","year":"2017","unstructured":"Arakawa, N. et al. Genome-wide analysis of DNA copy number alterations in early and advanced gastric cancers. Mol. Carcinog. 56, 527\u2013537. https:\/\/doi.org\/10.1002\/mc.22514 (2017).","journal-title":"Mol. Carcinog."},{"key":"96442_CR36","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41419-021-03904-4","volume":"12","author":"J Cao","year":"2021","unstructured":"Cao, J. et al. USP35, regulated by Estrogen and AKT, promotes breast tumorigenesis by stabilizing and enhancing transcriptional activity of Estrogen receptor alpha. Cell. Death Dis. 12, 619. https:\/\/doi.org\/10.1038\/s41419-021-03904-4 (2021).","journal-title":"Cell. Death Dis."},{"key":"96442_CR37","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3389\/fnins.2018.00937","volume":"12","author":"B Rebolledo-Jaramillo","year":"2018","unstructured":"Rebolledo-Jaramillo, B. & Ziegler, A. Teneurins: An integrative molecular, functional, and biomedical overview of their role in cancer. Front. Neurosci. 12, 937. https:\/\/doi.org\/10.3389\/fnins.2018.00937 (2018).","journal-title":"Front. Neurosci."},{"doi-asserted-by":"publisher","unstructured":"Ruiu, R. et al. Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer. Cancers (Basel) 13. https:\/\/doi.org\/10.3390\/cancers13040894 (2021).","key":"96442_CR38","DOI":"10.3390\/cancers13040894"},{"key":"96442_CR39","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nrc3792","volume":"14","author":"FJ Sulzmaier","year":"2014","unstructured":"Sulzmaier, F. J., Jean, C. & Schlaepfer, D. D. FAK in cancer: mechanistic findings and clinical applications. Nat. Rev. Cancer 14, 598\u2013610. https:\/\/doi.org\/10.1038\/nrc3792 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"96442_CR40","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3892\/ijo.2015.3019","volume":"47","author":"W Wattanawongdon","year":"2015","unstructured":"Wattanawongdon, W. et al. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness. Int. J. Oncol. 47, 398\u2013410. https:\/\/doi.org\/10.3892\/ijo.2015.3019 (2015).","journal-title":"Int. J. Oncol."},{"key":"96442_CR41","first-page":"52","volume":"15","author":"R Rosell","year":"2001","unstructured":"Rosell, R. et al. Novel approaches in the treatment of non-small-cell lung cancer. Oncol. (Williston Park) 15, 52\u201360 (2001).","journal-title":"Oncol. (Williston Park)"},{"key":"96442_CR42","doi-asserted-by":"publisher","first-page":"5865","DOI":"10.1158\/1078-0432.CCR-12-1807","volume":"18","author":"CD Hurst","year":"2012","unstructured":"Hurst, C. D., Platt, F. M., Taylor, C. F. & Knowles, M. A. Novel tumor subgroups of urothelial carcinoma of the bladder defined by integrated genomic analysis. Clin. Cancer Res. 18, 5865\u20135877. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1807 (2012).","journal-title":"Clin. Cancer Res."},{"key":"96442_CR43","doi-asserted-by":"publisher","first-page":"e0222140","DOI":"10.1371\/journal.pone.0222140","volume":"14","author":"M Suksawat","year":"2019","unstructured":"Suksawat, M. et al. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues. PLoS One 14, e0222140. https:\/\/doi.org\/10.1371\/journal.pone.0222140 (2019).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96442-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96442-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96442-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T17:19:36Z","timestamp":1744219176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96442-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96442"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96442-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"28 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The methods used in this study follow the guidelines of the Declaration of Helsinki and ICH Good Clinical Practice (ICH GCP) guidelines. This study was approved by The Ethics Committee for Human Research, Khon Kaen University, Thailand and signed informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11984"}}